Literature DB >> 9883796

Is there really a heterosexual AIDS epidemic in the United States? Findings from a multisite validation study, 1992-1995. Mode of Transmission Validation Study Group.

R M Klevens1, P L Fleming, J J Neal, J Li.   

Abstract

The objective of this study was to verify the mode of exposure to the human immunodeficiency virus (HIV) among cases who obtained acquired immunodeficiency syndrome (AIDS) through heterosexual contact and to determine the proportion of cases initially reported with no risk but whose exposure may have been heterosexual. Adults aged > or = 13 years with AIDS, diagnosed from 1992 through 1995 with heterosexual risk or no risk at six US study sites (Alabama, California, Florida, New Jersey, New York City, and Texas), were eligible. Heterosexual risk was validated in 82% (1,610/1,952) of the heterosexual cases. Men were more likely than women to have a risk other than heterosexual (24% vs. 13%, chi2 p < 0.01). An HIV risk was identified for 351 (55%) of those cases with no risk, and men were more likely than women to remain without risk (48% vs. 38%, chi2 P = 0.02). Of the 415 men with no risk, 215 (52%) were reclassified: 94 (44%) were men who had sex with men, 61 (28%) were injection drug users, 48 (22%) had a heterosexual risk, and 12 (6%) had other exposures. Of the 219 women with no risk, 136 (62%) were reclassified: 82 (60%) had a heterosexual risk, 47 (35%) were injection drug users, and 6 (4%) had infection associated with transfusion. In conclusion, most cases reported with heterosexually acquired AIDS had valid heterosexual risk exposures.

Entities:  

Mesh:

Year:  1999        PMID: 9883796     DOI: 10.1093/oxfordjournals.aje.a009730

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  The Changing Epidemic of HIV.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  Validation of race/ethnicity and transmission mode in the US HIV/AIDS reporting system.

Authors:  Lisa M Lee; J Stan Lehman; Andrew B Bindman; Patricia L Fleming
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

3.  Changes in HIV and AIDS in the United States: Entering the Third Decade.

Authors:  Scott Kellerman; Elin Begley; Brian Boyett; Hollie Clark; Jeff Schulden
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

Review 4.  Changes in HIV and AIDS in the United States: entering the third decade.

Authors:  Scott Kellerman; Elin Begley; Brian Boyett; Hollie Clark; Jeff Schulden
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

5.  Classification of transmission risk in the national HIV/AIDS surveillance system.

Authors:  Lisa M Lee; Matthew T McKenna; Robert S Janssen
Journal:  Public Health Rep       Date:  2003 Sep-Oct       Impact factor: 2.792

6.  Human rights is a US problem, too: the case of women and HIV.

Authors:  E L Gollub
Journal:  Am J Public Health       Date:  1999-10       Impact factor: 9.308

7.  Endothelial cell suppression of peripheral blood mononuclear cell trafficking in vitro during acute exposure to feline immunodeficiency virus.

Authors:  Lola C Hudson; Mary B Tompkins; Rick B Meeker
Journal:  Cell Tissue Res       Date:  2008-07-30       Impact factor: 5.249

8.  An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with men.

Authors:  Spencer Lieb; Samuel R Friedman; Mary Beth Zeni; Dale D Chitwood; Thomas M Liberti; Gary J Gates; Lisa R Metsch; Lorene M Maddox; Tamara Kuper
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

9.  Limitations of Canadian COVID-19 data reporting to the general public.

Authors:  Stephanie Long; David Loutfi; Jay S Kaufman; Tibor Schuster
Journal:  J Public Health Policy       Date:  2022-01-31       Impact factor: 3.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.